206 related articles for article (PubMed ID: 27896620)
1. Antimicrobial activity of topical agents against Propionibacterium acnes: an in vitro study of clinical isolates from a hospital in Shanghai, China.
Ma Y; Zhang N; Wu S; Huang H; Cao Y
Front Med; 2016 Dec; 10(4):517-521. PubMed ID: 27896620
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P
Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
[TBL] [Abstract][Full Text] [Related]
3. [In vitro sensitivity of Corynebacterium acnes (Propionibacterium acnes) to meclocycline, clindamycin, erythromycin and neomycin].
Lucca L; Vittadini G
G Ital Chemioter; 1979; 26(1-2):203-6. PubMed ID: 554810
[No Abstract] [Full Text] [Related]
4. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes.
Lim YH; Kim IH; Seo JJ
J Microbiol; 2007 Oct; 45(5):473-7. PubMed ID: 17978809
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
Gloor M; Wasik B; Becker A; Höffler U
Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
Mendoza N; Hernandez PO; Tyring SK; Haitz KA; Motta A
Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic susceptibility of
Zhu T; Zhu W; Wang Q; He L; Wu W; Liu J; Li Y; Sun D
BMJ Open; 2019 Feb; 9(2):e022938. PubMed ID: 30782869
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study.
Abdel Fattah NS; Darwish YW
J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1546-51. PubMed ID: 23279041
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S
Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
[TBL] [Abstract][Full Text] [Related]
11. Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia.
Jones RN; Li Q; Kohut B; Biedenbach DJ; Bell J; Turnidge JD
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):63-71. PubMed ID: 16368476
[TBL] [Abstract][Full Text] [Related]
12. In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory.
Leyden JJ
J Drugs Dermatol; 2012 Dec; 11(12):1434-8. PubMed ID: 23377513
[TBL] [Abstract][Full Text] [Related]
13. [Bacterial resistance in acne? A meta-analysis of the controversy].
Alvarez-Sánchez M; Rodríguez-Ayala E; Ponce-Olivera RM; Tirado-Sánchez A; Arellano-Mendoza MI
Cir Cir; 2016; 84(3):190-5. PubMed ID: 26738649
[TBL] [Abstract][Full Text] [Related]
14. Topical antibiotics and topical antimicrobial agents in acne therapy.
Leyden JJ; McGinley K; Mills OH; Kligman AM
Acta Derm Venereol Suppl (Stockh); 1980; Suppl 89():75-82. PubMed ID: 6451130
[No Abstract] [Full Text] [Related]
15. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
Owen L; Grootveld M; Arroo R; Ruiz-Rodado V; Price P; Laird K
Phytother Res; 2017 Mar; 31(3):410-417. PubMed ID: 28124400
[TBL] [Abstract][Full Text] [Related]
16. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
Nishijima S; Akamatsu H; Akamatsu M; Kurokawa I; Asada Y
J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270
[TBL] [Abstract][Full Text] [Related]
17. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
[TBL] [Abstract][Full Text] [Related]
18. [Phylotyping and Determining the Antimicrobial Susceptibility of Cutibacterium acnes Isolated from Patients with Acne Vulgaris].
Özel Kaya N; Usta İ; Demirçay ZÖ; Ülger Toprak N
Mikrobiyol Bul; 2021 Oct; 55(4):465-479. PubMed ID: 34666649
[TBL] [Abstract][Full Text] [Related]
19. In vitro antimicrobial susceptibility patterns of Propionibacterium acnes isolated from patients with acne vulgaris.
Biswal I; Gaind R; Kumar N; Mohanty S; Manchanda V; Khunger N; V R; Deb M
J Infect Dev Ctries; 2016 Oct; 10(10):1140-1145. PubMed ID: 27801379
[TBL] [Abstract][Full Text] [Related]
20. Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes.
Crawford WW; Crawford IP; Stoughton RB; Cornell RC
J Invest Dermatol; 1979 Apr; 72(4):187-90. PubMed ID: 429800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
